Vanguard Group Inc Biolife Solutions Inc Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,848,326 shares of BLFS stock, worth $75.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,848,326
Previous 2,786,464
2.22%
Holding current value
$75.5 Million
Previous $59.7 Million
19.39%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BLFS
# of Institutions
198Shares Held
44.9MCall Options Held
8.2KPut Options Held
4K-
Casdin Capital, LLC New York, NY8.71MShares$231 Million16.93% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$145 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.2MShares$84.9 Million0.02% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$41.8 Million0.2% of portfolio
-
State Street Corp Boston, MA1.41MShares$37.4 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.13B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...